AUC Analysis of Recombinant Protein Drugs

Recombinant protein drugs refer to protein products that originate from animals or plants and are developed through biotechnological research. These proteins have biological activity and can prevent, diagnose, and treat diseases in humans, animals, and plants. Compared to small molecule drugs, recombinant protein drugs have advantages such as high activity, high specificity, and low toxicity, thus they are favored by many researchers. Currently, recombinant protein drugs are widely used in various fields including tumors, autoimmune diseases, metabolic diseases, geriatric diseases, and degenerative diseases.

 

Analytical Ultracentrifugation (AUC) has a wide range of applications in the research and development of recombinant protein drugs. AUC uses centrifugal force and time to analyze the sedimentation behavior of molecules in a solution, providing important information about the structure, interaction, and purity of proteins. The specific applications of AUC in recombinant protein drugs include: (1) analysis of protein purity and aggregates; (2) studying the interaction and formation of complexes of recombinant protein drugs; (3) evaluating the stability and kinetic aspects of protein aggregation; (4) quality control in the development of recombinant protein drugs.

 

MtoZ Biolabs offers high-resolution and high-sensitivity AUC technology services for your recombinant protein drugs. This technology is widely used in the research and development process of recombinant protein drugs and can provide important information about the structure, interaction, purity, stability, and kinetics of protein aggregation. This information is of great significance for the research and development, quality control, and efficacy evaluation of protein drugs.